Quantum Biopharma (QNTM) Cash from Investing Activities (2020 - 2026)
Quantum Biopharma recorded quarterly Cash from Investing Activities of -$2.9 million in Q1 2026, down 925.11% quarter-over-quarter from $350650.0 in Q4 2025, and down 114.28% year-over-year from $20.3 million in Q1 2025.
Quantum Biopharma's Cash from Investing Activities history runs 6 years deep, the most recent figure standing at -$2.9 million for Q1 2026.
- In Q1 2026, Cash from Investing Activities fell 114.28% year-over-year to -$2.9 million; the TTM figure through Mar 2026 stood at -$2.6 million (down 122.49% YoY), while the FY2025 annual figure was -$2.0 million, down 29.86% from the prior year.
- Cash from Investing Activities came in at -$2.9 million for Q1 2026 at Quantum Biopharma, down from $350650.0 in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $11.9 million in Q4 2022 to a low of -$2.9 million in Q1 2026.
- A 4-year average of $1.3 million and a median of -$22140.0 in 2024 frame the typical range for Cash from Investing Activities.
- On a YoY basis, Cash from Investing Activities climbed as much as 71.81% in 2025 and fell as far as 5998.5% in 2025.
- Quantum Biopharma's Cash from Investing Activities stood at $11.9 million in 2022, then slumped by 89.55% to $1.2 million in 2024, then slumped by 71.81% to $350650.0 in 2025, then tumbled by 925.11% to -$2.9 million in 2026.
- According to Business Quant data, Cash from Investing Activities over the past three periods registered -$2.9 million, $350650.0, and -$1.4 million for Q1 2026, Q4 2025, and Q1 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.89 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 638.50 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -431.90 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -428.90 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -25.54 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | 172.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.89 Mn |
| Mar 31, 2026 | -2.89 Mn |
| Dec 31, 2025 | 350,650.00 |
| Dec 31, 2025 | 350,650.00 |
| Mar 31, 2025 | -1.35 Mn |
| Mar 31, 2025 | -1.35 Mn |
| Dec 31, 2024 | 1.24 Mn |
| Dec 31, 2024 | 1.24 Mn |
| Mar 31, 2024 | -22,140.00 |
| Mar 31, 2024 | -22,140.00 |
| Dec 31, 2022 | 11.91 Mn |
| Dec 31, 2022 | 11.91 Mn |
| Mar 31, 2022 | -106,586.00 |
| Mar 31, 2022 | -106,586.00 |
| Mar 31, 2021 | 500,000.00 |
| Mar 31, 2021 | 500,000.00 |
| Sep 30, 2020 | 1.68 Mn |
| Sep 30, 2020 | 1.68 Mn |
| Jun 30, 2020 | 394,459.61 |
| Jun 30, 2020 | 394,459.61 |
| Mar 31, 2020 | 4.35 Mn |
| Mar 31, 2020 | 4.35 Mn |